Bio Rad Laboratories Inc reports results for the quarter ended June 30 - Earnings Summary

• Bio Rad Laboratories Inc BIO reported quarterly adjusted earnings of $2.61​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $3.11. The mean expectation of seven analysts for the quarter was for earnings of $1.73 per share. Wall Street expected results to range from $1.60 to $1.92 per share.

• Revenue rose 2.1% to $651.60 million from a year ago; analysts expected $615.21 million.

• Bio Rad Laboratories Inc's reported EPS for the quarter was $11.67​.

• The company reported quarterly net income of $317.8 million.

• Bio Rad Laboratories Inc shares had risen by 3.6% this quarter and lost 23.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 19.7% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for Bio Rad Laboratories Inc is $317.50, about 23.8% above its last closing price of $241.95

This summary was machine generated from LSEG data July 31 at 09:36 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)